课题基金 / 基金详情

Zwitterionic oxime (RS194B) to reverse advanced symptoms and lethality of organophosphate pesticide exposure

Zwitterionic oxime (RS194B) to reverse advanced symptoms and lethality of organophosphate pesticide exposure
两性离子肟 (RS194B) 可逆转有机磷农药暴露的晚期症状和致死率
批准号:
9621314
负责人:
Yvonne J Rosenberg
金额:
$22.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2020-04-30

项目摘要

项目成果

Yvonne J Rosenberg的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 神经肌肉接头、外周自主神经元和中枢神经元中AChE的抑制 突触,并对循环红细胞是与毒性的所有有机磷 杀虫剂治疗通常涉及毒蕈碱拮抗剂(阿托品)与 吡啶醛肟,例如解磷定(2-PAM)和双肟,能够使OP- 抑制乙酰胆碱酯酶,与/不与抗惊厥药(地西泮)控制癫痫发作。然而,动物 使用农药中毒个体的模型研究和最近的临床试验显示, 这些肟的临床贝内,甚至是危害,因此它们作为解毒剂的真正功效一直是 辩论。目前使用的肟或者再活化差,不容易穿过BBB, 迅速从循环中清除。因此,它们必须反复施用。最近,博士。 加州大学圣地亚哥分校帕尔默·泰勒(Palmer Taylor)的实验室开发出了结构简单的两性离子肟,例如艾德 RS 194 B,有效地穿过血脑屏障(BBB),导致OP-1的快速再活化。 抑制乙酰胆碱酯酶和戏剧性逆转严重的临床症状的小鼠和猕猴接触 OP杀虫剂或神经毒剂。在最近的一项PlantVax猕猴研究中, 致命剂量的OP杀虫剂对氧磷,通过吸入传递,引起临床症状, 类似于杀虫剂中毒的人。这可能是一个不寻常的结果, 除猕猴的肺外,雾化OP主要沉积在胃中 和小孩子相比,在成年人中看到的。 了解急性和慢性影响的挑战和治疗的不同 有机磷农药的体内毒力和肟的显著变异性导致了有机磷农药的产生 在相同或不同的动物物种的反应。一般来说,抑制和再激活 猪、大鼠和豚鼠AChE暴露于各种OP杀虫剂(Px)或神经 对人类和非人类灵长类动物使用沙林、环沙林、VX毒气的速度要慢。这项I期 该提案是第一个评估中枢作用肟RS 194 B重新激活 硫代磷酸酯杀虫剂的体外和体内研究。最初,猕猴的肟活化和 被一组二乙基和二甲基硫代磷酸酯杀虫剂抑制人rAChE将 评估RS 194 B重新激活AChE和逆转临床体征的功效, 将评估暴露于选定的常用杀虫剂的猕猴。相似 猕猴和人类的生化/药理学特性和再活化动力学, 杀虫剂中毒后的共同临床症状应允许合理的动物- 人外推,并为使用猴进行RS 194 B体内评价提供支持。
英文摘要
ABSTRACT Inhibition of AChE in the neuromuscular junction, peripheral autonomic and central neuron synapses, and on circulating red blood cells is associated with the toxicity for all organophosphate insecticides. Treatment typically involves the muscarinic antagonist (atropine) in combination with a pyridinium aldoxime, eg pralidoxime (2-PAM) and obidoxime, capable of reactivating the OP- inhibited AChE, with/without an anti-convulsant (diazepam) to control seizures. However, animal model studies and recent clinical trials using pesticide-poisoned individuals have shown uneven clinical benefits of these oximes and even harm so their true efficacy as antidotes has been debated. Currently used oximes either reactivate poorly, do not readily cross the BBB and are rapidly cleared from the circulation. Hence, they must be repeatedly administered. Recently, Dr. Palmer Taylor's lab at UCSD has developed zwitterionic oximes of simplified structure eg RS194B, that efficiently cross the blood-brain-barrier (BBB) resulting in rapid reactivation of OP- inhibited AChE and dramatic reversal of severe clinical symptoms in mice and macaques exposed to OP insecticide or nerve agents. In a recent PlantVax macaque study, it was observed that a lethal dose of the OP insecticide paraoxon, delivered by inhalation, caused clinical symptoms very similar to those in insecticide poisoned people. This probably is a consequence of the unusual deposition of nebulized OP predominantly in the stomach in addition to the lungs in macaques and small children in contrast to that seen in adult humans. The challenges to understanding the acute and chronic effects of and treatments for different OP pesticides result from significant variability in their in vivo toxicokinetics and oxime responsiveness in the same or different animal species. In general, the inhibition and reactivation kinetics with swine, rat and guinea pig AChE exposed to a variety of OP insecticides (Px) or nerve agents (sarin, cyclosarin, VX) are slower than for humans and non-human primates. This Phase I proposal, is the first to evaluate the efficacy of a centrally acting oxime RS194B to reactivate phosphorothioate insecticides in vitro and in vivo. Initially, oxime reactivation of macaque and human rAChE inhibited by a panel of both diethyl- and dimethylphosphorothioate insecticides will be assessed and subsequently, RS194B efficacy to reactivate AChE and reverse clinical signs in macaques exposed to selected commonly used insecticides will be assessed. The similar biochemical/pharmacological properties and reactivation kinetics in macaques and humans and the shared clinical symptoms following insecticide poisoning should allow a reasonable animal-to- human extrapolation and provide support for the use of monkeys for in vivo evaluation of RS194B.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing
  • 批准号:
    10079784
  • 项目类别:
  • 资助金额:
    $70.58万
  • 财政年份:
    2018
  • 负责人:
    Yvonne J Rosenberg
  • 依托单位:
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing
  • 批准号:
    10259769
  • 项目类别:
  • 资助金额:
    $51.51万
  • 财政年份:
    2018
  • 负责人:
    Yvonne J Rosenberg
  • 依托单位:
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques
  • 批准号:
    9312216
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2016
  • 负责人:
    Yvonne J Rosenberg
  • 依托单位:
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm
  • 批准号:
    8738719
  • 项目类别:
  • 资助金额:
    $85.89万
  • 财政年份:
    2009
  • 负责人:
    Yvonne J Rosenberg
  • 依托单位:
海外基金